NCT00006225View on ClinicalTrials.gov

Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 1999

Primary Completion Date

January 31, 2004

Study Completion Date

January 31, 2004

Conditions
Breast CancerLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic/Myeloproliferative Diseases
Interventions
BIOLOGICAL

filgrastim

BIOLOGICAL

recombinant flt3 ligand

BIOLOGICAL

recombinant human thrombopoietin

BIOLOGICAL

recombinant interleukin-3

PROCEDURE

in vitro-treated peripheral blood stem cell transplantation

Trial Locations (1)

60611

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT00006225 - Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer | Biotech Hunter | Biotech Hunter